About

Aims and scope

Journal of Investigative Medicine (JIM) is the official publication of the American Federation for Medical Research. The journal is peer-reviewed and publishes high-quality original articles and reviews in the areas of basic, clinical, and translational medical research.

JIM publishes on all topics and specialty areas that are critical to the conduct of the entire spectrum of biomedical research: from the translation of clinical observations at the bedside, to basic and animal research to clinical research and the implementation of innovative medical care.

The journal aims to provide rapid publication of research through its continuous online publication model. Submissions should be made through the journal’s new online submission system. Articles should not be under review or under consideration by any other journal when submitted to JIM.

JIM is a member journal of the Committee on Publication Ethics (COPE) and is a sponsor of the Equator Network, which is an international initiative that promotes transparent, accurate reporting of research studies.

American Federation for Medical Research members enjoy free access to JIM as part of their member benefits. Members can login here.

American Federation for Medical Research

Established in 1940, the American Federation for Medical Research (AFMR) is an international multi-disciplinary association of scientists engaged in all areas of biomedical investigation-patient-oriented, translational, and basic research. Members are located at government facilities, medical centers, research institutions, and private industry in all 50 states and throughout the world. AFMR fosters research in the medical sciences, provides leadership in articulating and publicizing the aims and goals of scientific research, disseminates the knowledge medical research generates, and identifies and supports efforts to achieve these objectives.

AFMR repeatedly demonstrates how clinical and basic research efforts integrate to provide the scientific basis for medical practice. AFMR’s translational aspect has broad reaching clinical applications and strengthens the fields of scientific study based in multiple medical disciplines.

American Federation for Medical Research
500 Cummings Center | Suite 4400 | Beverly, MA 01915
Phone: 978-927-8330
Fax: 978-524-0498

Journal statistics

Frequency 8 issues/year
Impact Factor 1.943
Indexed by Index Medicus (Medline), ISI Current Contents (Web of Science), Google Scholar, PubMed, Scopus
Launch date 1995
ISSN 1081-5589
ISSN (online) 1708-8267

To advertise

Affiliations

AFMR logo

Established in 1940, the American Federation for Medical Research is an international multi-disciplinary association of scientists engaged in all areas of biomedical investigation-patient-oriented, translational, and basic research. Members can login here.

Dryad logo

Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.

COPE logo

The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

OASPA

The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. The BMJ Publishing Group has been a member since 2009.

CreativeCommons

Open Access articles in Journal of Investigative Medicine are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.